These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6426113)

  • 21. Allopurinol for stones: right drug--wrong reasons.
    Grover PK; Ryall RL
    Am J Med; 2007 May; 120(5):380. PubMed ID: 17466643
    [No Abstract]   [Full Text] [Related]  

  • 22. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER; Cohanim M
    Clin Invest Med; 1986; 9(1):44-50. PubMed ID: 3955921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rice bran in the treatment of idiopathic hypercalciuria in patients with urinary calculosis].
    Noronha IL; Andriolo A; Lucon AM; Wroclawski ER; Chade J; Borelli A; Leite MO; Sabbaga E; Arap S
    Rev Paul Med; 1989; 107(1):19-24. PubMed ID: 2616974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypercalciuria and postglomerular hematuria in children. The effects of thiazide on calcium excretion, urine saturation with respect to calcium-hydrogenphosphate and hematuria.
    Reusz G; Szabó A
    Acta Paediatr Hung; 1990; 30(1):63-71. PubMed ID: 2317387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal tubular function in children with hypercalciuria].
    Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O
    Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of hydrochlorothiazide on the renal excretion of oxalic acid and on the formation of oxalate stones in the urinary tract.
    Glazenburg J
    Arch Chir Neerl; 1971; 23(3):217-23. PubMed ID: 5121595
    [No Abstract]   [Full Text] [Related]  

  • 30. [Efficacy of thiazide in idiopathic calcium urolithiasis. Results of a one-year double-blind study (author's transl)].
    Scholz D; Schwille PO
    Arzneimittelforschung; 1980; 30(11):1928-32. PubMed ID: 7006616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid hormone and electrolytes during long-term treatment with allopurinol and thiazide.
    Kohri K; Takada M; Katoh Y; Kataoka K; Iguchi M; Yachiku S; Kurita T
    Br J Urol; 1987 Jun; 59(6):503-7. PubMed ID: 3690177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences.
    Borghi L; Meschi T; Guerra A; Novarini A
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S78-86. PubMed ID: 7508066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phosphate therapy of recurrent calcium calculus disease. Current status].
    Schneider HJ; Rugendorff EW
    Fortschr Med; 1985 Feb; 103(5):104-6. PubMed ID: 3972326
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term treatment and prevention of uric acid urolithiasis with allopurinol].
    Jarrar K
    Fortschr Med; 1982 May; 100(20):967-8. PubMed ID: 6807789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Renal electrolyte changes by allopurinol. A contribution in the prophylaxis of oxalic acid stones (author's transl)].
    Garke P; Terhorst B
    Urologe A; 1974 Jul; 13(4 Pt A):166-7. PubMed ID: 4212796
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dietary control for out-patients in urinary stone clinic].
    Kato T; Yanagawa M; Hioki T; Sakurai M; Yamakawa K; Araki T; Yamamoto I; Arima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1993 Jul; 39(7):593-8. PubMed ID: 8362676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thiazides reduce brushite, but not calcium oxalate, supersaturation, and stone formation in genetic hypercalciuric stone-forming rats.
    Bushinsky DA; Asplin JR
    J Am Soc Nephrol; 2005 Feb; 16(2):417-24. PubMed ID: 15647340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K; Topal C; Erkoc R; Sayarlioglu H; Can S; Yilmaz Y; Dogan E; Algun E; Gonulalan H
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hydrochlorothiazide and diet in dogs with calcium oxalate urolithiasis.
    Lulich JP; Osborne CA; Lekcharoensuk C; Kirk CA; Allen TA
    J Am Vet Med Assoc; 2001 May; 218(10):1583-6. PubMed ID: 11393368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria.
    Preminger GM; Pak CY
    J Urol; 1987 Jun; 137(6):1104-9. PubMed ID: 3586136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.